PetIQ, Inc. (PETQ) Misses Q4 EPS by 51c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2021 Financial Results
March 1, 2022 4:05 PM ESTReports Fourth Quarter Net Sales of $196.6 Million and Full Year Net Sales of $932.5 Million
Company Provides First Quarter 2022 and Full Year 2022 Outlook
EAGLE, Idaho, March 01, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the fourth quarter and full year ended December 31, 2021.
Cord Christensen, PetIQs Chairman & CEO commented, We are very pleased with our strong finish to 2021. Our record fourth quarter was better than we expected driven by... More



